XML 24 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows
$ in Millions
 6 Months Ended
Jun. 30, 2021
USD ($)
Jun. 30, 2020
USD ($)
Cash flows from operating activities:    
Net income $ 242.7 $ 271.0
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 82.6 78.5
Amortization of debt issuance cost and debt discount 1.4 1.0
Realized gain on available-for-sale financial investments   (0.4)
Provision for accounts receivable credit losses 0.5 0.4
Provision for deferred income taxes 5.9 (11.0)
Stock-based compensation expense 17.2 12.9
Impairment of property held for sale   8.1
Impairment charge of investment 0.6  
Equity earnings in investments 0.4 (0.7)
Changes in assets and liabilities:    
Accounts receivable 4.2 (144.2)
Restricted cash and cash equivalents (margin deposits and clearing fund) 376.1  
Income taxes receivable 13.3 56.8
Other current assets (21.7) (1.8)
Other assets (15.9) (12.1)
Accounts payable and accrued liabilities 9.6 45.3
Section 31 fees payable (31.9) 148.5
Deferred revenue 7.0 11.6
Income taxes payable 0.6 11.1
Unrecognized tax benefits 22.8 12.9
Other liabilities 6.4 0.4
Net cash provided by operating activities 721.8 488.3
Cash flows from investing activities:    
Acquisitions, net of cash acquired   (66.6)
Proceeds from acquisition-related escrow 0.5  
Purchases of available-for-sale financial investments (92.6) (154.9)
Proceeds from maturities of available-for-sale financial investments 67.6 47.3
Return of capital from investments   4.5
Contributions to investments   (4.7)
Purchases of property and equipment (21.3) (17.2)
Net cash used in investing activities (45.8) (191.6)
Cash flows from financing activities:    
Principal payments of current portion of long-term debt (20.0)  
Proceeds from term loan 110.0  
Cash dividends on common stock (90.3) (79.5)
Repurchases of common stock from employee stock plans (5.8) (14.1)
Exercise of common stock options   0.2
Payment of contingent consideration from acquisition (6.5) (2.2)
Shares issued under employee stock purchase plan (0.2)  
Purchase of common stock (81.3) (219.3)
Net cash used in financing activities (94.1) (314.9)
Effect of foreign currency exchange rates on cash, cash equivalents, and restricted cash and cash equivalents (0.3) (1.0)
Increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents 581.6 (19.2)
Cash, cash equivalents, and restricted cash and cash equivalents: Beginning of period 1,057.5 229.3
Cash, cash equivalents, and restricted cash and cash equivalents: End of period 1,639.1 210.1
Supplemental disclosure of cash transactions:    
Cash paid for income taxes 95.1 33.3
Cash paid for interest $ 21.1 14.4
Supplemental disclosure of noncash investing activities:    
Accounts receivable acquired   0.7
Other current assets acquired   0.4
Goodwill acquired   66.4
Intangible assets acquired   22.3
Accounts payable and accrued expenses assumed   (1.4)
Deferred revenue acquired   (1.3)
Contingent consideration related to acquisitions   $ (20.5)